EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening

Guihua Lai, Qiying Gu, Zhiyong Lai, Haijun Chen, Xiangwen Tu, Junkun Chen, Jungao Huang

Frontiers in Public Health · 2024

DOI: 10.3389/fpubh.2024.1461141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Public Health, 2024. Verfasst von Guihua Lai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, Ganzhou Maternal and Child Health Hospital, Ganzhou, Jiangxi, China. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, High-Throughput Nucleotide Sequencing, Neonatal Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tandem mass spectrometry (MS/MS) is a crucial technique for detecting inborn errors of metabolism (IEM) in newborns. However, the high false positive rate poses challenges in diagnosing specific types of diseases. Therefore, this study aimed to evaluate the role of targeted next-generation sequencing (NGS) in the accurate diagnosis of positive samples identified through MS/MS screening.

Methods

A cohort study of 260,915 newborns was conducted from January 2018 to June 2023 in Ganzhou City, southern China. Heel blood samples were collected within 72 h of birth and subjected to MS/MS analysis. Infants with positive MS/MS results underwent targeted NGS to confirm the diagnosis and identify genetic variants.

Results

Among 1,265 suspected cases with positive MS/MS results, 73 were confirmed by NGS, and 12 were identified as carriers of recessive diseases. The overall incidence rate was 1 in 3,574, effectively ruling out 94.2% (1,192/1,265) of the MS/MS false-positive. We found 76 variants in 18 genes associated with 15 types of IEM. Among these, 64.47% (49/76) were pathogenic, 10.53% (8/76) were likely pathogenic. Remarkably, 7.89% (6/76) were identified as novel variants. Variants in SLC22A5 (NM_003060.4) gene was most prevalent, accounting for 41% (77/188), with hotspot variants including c.51C > G, c.1400C > G, and c.338G > A.

Conclusion

Targeted NGS technology can serve as a crucial diagnostic tool for neonatal genetic metabolic diseases following MS/MS screening. Additionally, we identified IEM variant hotspots and some novel variants in our region, which are the underlying causes of disease in patients with IEM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometryHigh-Throughput Nucleotide SequencingNeonatal ScreeningHumansInfant, NewbornChinaFemaleMaleMetabolism, Inborn ErrorsCohort Studies

Stichwörter der Autor:innen

genetic diagnosisinborn errors of metabolismnewborn screeningtandem mass spectrometrytargeted sequencing

Autor:innen und Institutionen

  • Central Laboratory, Ganzhou Maternal and Child Health Hospital, Ganzhou, Jiangxi, China.

Zitieren

APA

Lai, G., Gu, Q., Lai, Z., Chen, H., Tu, X., Chen, J., & Huang, J. (2024). Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening. Frontiers in Public Health. https://doi.org/10.3389/fpubh.2024.1461141

Vancouver

Lai G, Gu Q, Lai Z, Chen H, Tu X, Chen J, et al. Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening. Frontiers in Public Health. 2024. doi:10.3389/fpubh.2024.1461141

BibTeX
@article{Lai2024,
  author = {Lai, Guihua and Gu, Qiying and Lai, Zhiyong and Chen, Haijun and Tu, Xiangwen and Chen, Junkun and Huang, Jungao},
  title = {Application of targeted high-throughput sequencing as a diagnostic tool for neonatal genetic metabolic diseases following tandem mass spectrometry screening},
  journal = {Frontiers in Public Health},
  year = {2024},
  doi = {10.3389/fpubh.2024.1461141}
}
Kostenlos starten →